Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-05-01

FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Supplemental Application (Northstar RxLLC)

View source ↗

Summary

FDA approved a supplemental application for Amoxicillin and clavulanate potassium (amoxicillin-clavulanate) from Northstar RxLLC, authorizing changes to this ge…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMOXICILLIN AND CLAVULANATE POTASSIUM (amoxicillin and clavulanate potassium)

Snippet

SUPPL AP for AMOXICILLIN AND CLAVULANATE POTASSIUM (AMOXICILLIN AND CLAVULANATE POTASSIUM)